neurodegeneration and dementia Flashcards

(42 cards)

1
Q

features shared by NDD

A

progressive - once disease process has begun it continues relentlessly
fatal outcome
associtaed with aging
degeneration of neurones - dysfunction and cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

many of these diseases are caused by

A

abnormal accumulation of proteins in the CNS

mostly unknown causes - genetic and environmental factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

common pathological factors

A

cmmonest in old age
each disease affects specific neuronal groups
clinical features relate to the anatomy and function of the affected areas
atrophy of affected areas with disease progression - seen on imaging or macroscopically at PM
regional pattern of atrophy may be pathognomonic in some cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

microscope appearance of NDD

A

histopathology shows neuronal loss with variable gliosis
microscopy may show distinctiive cellular inclusions containing specific proteins in either neurones of glial cells eg. NFT, lewy bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cortical degenerations

A

alzhiemer disease
frontotemporal lobar degeneration
dementia with lewy bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

akinetic movement disorders

A

parkinsons disease
progressive supranuclear palsy
corticobasal degeneration
multiple ssystem atrophy (striatonigral degeneration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

hyperkinetic syndroms

A

huntington disease

choreoarthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

cerebellar ataxis

A

inherited and sporadic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

diseases of motor systems

A

motor neurone disease

hereditary spastic paraperesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

autonomic disorders

A

parkinosns disease

multiple system atrophy (shy-drager syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hippocapmus diseases

A

congnitive changes, memory, behaviour, language

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

basal ganglia diseases

A

movement disorders
hypokinetic
hyperkinetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cerebellum diseases

A

ataxia - psinocerebellar ataxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

motor system diseases

A

weakness, difficulty swallowing, respiration, amyotropic lateral sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

protein accumulation

A

Ab amyloid - alzhiemers
Tau - pick disease (3 repeat) or others with 4 repeats
alpha-synuclein
TDP-43
polyglutamine repeat expansions - huntington disease
SOD1, TDP-43
prions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

dementia

A

an acquired progressive global impairment of intellect, memory and personality, without impairment of consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

the definition of dementia excludes

A

acute confusional state
impairment of consciousness
delirium or depression
mental impairment due to maldevelopment of the brain or due to a brain insult during development

18
Q

main causes of demntia

A

alziemerhs
dementia with lewy bodies
frontotemporal lobar degeneration
vescular pathology

19
Q

alzheimers disease

A

progressive and inevitably fatal within 5-15 years
immidiate cause of death often terminal infection eg. pneumonia
3rd most common death in developed world (after vascular disease and cancer)

20
Q

ealry onset alzheimers

21
Q

gold standard for alzeimhers diagnossis

A

post mortem pathology

22
Q

changes in the brain

A

reduction in size and atrophy
ventricle increases in size due to decrease volume of white matter
sulci appear expanded and gyri are narrowed
reduced cerebral weight
atrophy of medial temporal lobe

23
Q

histopathological features of alzheimers

A

amyloid b-protein accumulation - cortical neuritic plaques and cerebral amyloid angiopathy
tau accumulation - neurofibrillary tangles, plaque - associated dystrophic neurites and neuropil threads

24
Q

the amyloid hypothesis

A

abnormal accumulation of amyloid b protein through to play a key role in initiating and perpetuating the neurotoxic events that culminate in dementia (by reduced clearance rather than increased production
released into the ECS where it aggregates to form plaques and accumulates in vessel walls as CAA

25
genetic risks for alzheimers
ApoE4 allele is the only recognised risk factor familial form - mutations in presenilin 1 or presenilin 2 leading to early onset alzheimers trisomy 21 - alzheimers by 35yrs
26
diagnostic criteria fro AD
ABC score thal phase - of amyloid plaques (beta-amylloid stain) braak stage - of neurofibillary tangles (tau AT8 stain) CERAD stage of neuritic plaques (bielschowsky stain)
27
frontotemporal lobar degeneration (FTLD)
pathological correlate of FTD progressive frontal lobe dysfunction that may be followed by temporal lobe symptomatology behaviour and language problems precede memory problems onset younger than for alzheimers
28
FTLD is divided by
divided into several subgroups that are distinguished according to type of protein deposited on immunohistochemistry (Tau, TDP-43, FUS, UPS)
29
FTLD macroscopic
severe frontotemporal atrophy variable other findings pallor of pigmented nuclei in the brainstem in some entities
30
NDD with clinical features of parkinsonism
several different disease affecting the same circuitries in the network of neurones in the brain can result n similar clinical findings many of these movement disorders are sassociated with dementia only able to be distinguished on neuropathological examination
31
clinical features of parkinosnism
``` head bent forward tremors of the head mask-like facial expression drooling rigidity stooped posture weight loss tremor akinesia loss of postural reflexes done demineralization shuffling and propulsive gait bradykinesia pill-rolling tremor festinant gait ```
32
causes of parkinsonism
``` parkinsons disease dementia with lewy bodies multiple system atrophy tauopathies trinucleotide repeat diseases symptomatic parkinsomism - toxic eg. carbon monoxide, carbon sulphide, manganese drug induced - butyrophenones, phenotiazines, fluraridine, reserpine vascular parkinonsim ```
33
synucleinopathies
alpha-synuclein found to be major component in several cytoplasmic inclusions protein involved in synaptic transmission
34
dementia with lewy bodies
2nd most common dementia, 10-25% of cases fluctuating cognitive impairment, visual hallucinations, parkinsonism autonomic dysfunction sleep difficulty - REM sleep behaviour disorder depression apathy DLB = cognitive impairment first, movement later
35
huntington disorder
``` AD movement disorder - hyperkinetic degeneration of the striatum relentless progression CAG trinucleotide repeat anticipation ```
36
progression of huntington disorder
early cognitive symptoms, mood disorder progression to severe dementia death in 15 years on average
37
the prion hypothesis
PrPc is a normal cellular tranmembrane protein of uncertain function prion disease is due to an abnormally folded form of the protein (PrPsc) with has a tendancy to aggregate in the ECS and causing spongiform change
38
creutzfelt jakob disease
most common prion disease myoclonus and characteristic EEG changes occur late can be inherited as AD trait, can bbe acquired by tranmission or occur spontaneosly
39
tranmission of cruetzfelt jakob disease
person to person tansmission requires parenteral innoculation of infected tissue (iatrogenic) - incubation period ranges from years to decades
40
diagnosis of cruetzfelt jakob disease
requires histology
41
CJD autopsiess
requires special decontamination procedurres | needs full PPE and self contained breathing devices
42
CJD histology
microscopic vacuolaton of gray matter - spongiform change extra cellular accumulation of protease resistant peptide (PrP - prio protein) neuronal loss and gliosis